8q12 microduplication syndrome

8q12 microduplication syndrome (Orphanet code 228399) is a rare chromosomal anomaly caused by a small duplication of genetic material on the long arm of chromosome 8 at band q12. This region includes the CHRNA2 gene and other genes whose duplication contributes to the clinical phenotype. The syndrome primarily affects neurodevelopment and can involve multiple body systems. It is sometimes considered the reciprocal condition of the 8q12 microdeletion syndrome (which involves the TCOF1 gene region and is associated with Charge-like features), though the clinical presentation of the duplication is distinct. Key clinical features of 8q12 microduplication syndrome include mild to moderate intellectual disability, speech and language delay, behavioral abnormalities, and variable dysmorphic facial features. Some patients may present with hypotonia, seizures, and mild congenital anomalies. Growth parameters can be variable, with some individuals showing short stature or failure to thrive. The severity and range of symptoms can differ significantly between affected individuals, even within the same family, depending on the exact size and gene content of the duplicated segment. There is currently no specific or curative treatment for 8q12 microduplication syndrome. Management is supportive and symptom-based, typically involving early intervention programs, speech therapy, occupational therapy, and special educational support. Seizures, if present, are managed with standard antiepileptic medications. Regular developmental assessments and multidisciplinary follow-up are recommended to optimize outcomes. Genetic counseling is advised for affected families to discuss recurrence risk and inheritance patterns.

Common questions about 8q12 microduplication syndrome